Kamdar Kim P.
Insider CIK 1535065 · OCRX 10% owner · TBRA 10% owner · CADX 10% owner · SNDX Director, 10% owner · OBLN Director · SERA Director · DRTX 10% owner · NEOT Director, 10% owner · OMIC Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SERA SERA PROGNOSTICS, INC. | A Award deriv | 2026-07-10 | 2026-07-14 | 34,494 | — | $0 | 34,494 | SEC↗ |
| SERA SERA PROGNOSTICS, INC. | A Award deriv | 2026-07-10 | 2026-07-14 | 5,263 | — | $0 | 5,263 | SEC↗ |
| SERA SERA PROGNOSTICS, INC. | A Award | 2026-07-10 | 2026-07-14 | 22,426 | — | $0 | 54,999 | SEC↗ |
| SERA SERA PROGNOSTICS, INC. | A Award | 2026-07-10 | 2026-07-14 | 3,421 | — | $0 | 58,420 | SEC↗ |
| SERA SERA PROGNOSTICS, INC. | J Other | 2026-02-04 | 2026-02-04 | 3,231 | — | $0 | 32,573 | SEC↗ |
| SERA SERA PROGNOSTICS, INC. | J Other | 2026-02-04 | 2026-02-04 | 30,920 | — | $0 | 0 | SEC↗ |
| SERA SERA PROGNOSTICS, INC. | A Award deriv | 2025-06-05 | 2025-06-06 | 25,000 | — | $0 | 25,000 | SEC↗ |
| SERA SERA PROGNOSTICS, INC. | A Award | 2025-06-05 | 2025-06-06 | 15,596 | — | $0 | 29,342 | SEC↗ |
| OMIC Singular Genomics Systems, | D To issuer deriv | 2025-02-21 | 2025-02-25 | 666 | — | $0 | 0 | SEC↗ |
| OMIC Singular Genomics Systems, | D To issuer deriv | 2025-02-21 | 2025-02-25 | 2,466 | — | $0 | 0 | SEC↗ |
| OMIC Singular Genomics Systems, | D To issuer deriv | 2025-02-21 | 2025-02-25 | 1,541 | — | $0 | 0 | SEC↗ |
| OMIC Singular Genomics Systems, | D To issuer deriv | 2025-02-21 | 2025-02-25 | 2,466 | $8.84 | $21.8K | 0 | SEC↗ |
| OMIC Singular Genomics Systems, | D To issuer | 2025-02-21 | 2025-02-25 | 3,763,985 | — | $0 | 0 | SEC↗ |
| OMIC Singular Genomics Systems, | D To issuer | 2025-02-21 | 2025-02-25 | 15,000 | — | $0 | 0 | SEC↗ |
| OMIC Singular Genomics Systems, | D To issuer | 2025-02-21 | 2025-02-25 | 15,000 | — | $0 | 0 | SEC↗ |
| SERA SERA PROGNOSTICS, INC. | A Award deriv | 2024-06-06 | 2024-06-07 | 10,549 | — | $0 | 10,549 | SEC↗ |
| SERA SERA PROGNOSTICS, INC. | A Award | 2024-06-06 | 2024-06-07 | 7,117 | — | $0 | 13,746 | SEC↗ |
| OMIC Singular Genomics Systems, | A Award deriv | 2024-05-29 | 2024-05-31 | 74,000 | — | $0 | 74,000 | SEC↗ |
| EVFM Evofem Biosciences, Inc. | S Sale | 2023-12-21 | 2023-12-22 | 10 | $0.62 | $6 | 0 | SEC↗ |
| OMIC Singular Genomics Systems, | S Sale | 2023-08-15 | 2023-08-15 | 200,000 | $0.53 | $106.0K | 3,763,985 | SEC↗ |
| OMIC Singular Genomics Systems, | S Sale | 2023-08-14 | 2023-08-15 | 77,991 | $0.57 | $44.5K | 3,963,985 | SEC↗ |
| OMIC Singular Genomics Systems, | S Sale | 2023-08-11 | 2023-08-15 | 353,657 | $0.60 | $212.2K | 4,041,976 | SEC↗ |
| SERA SERA PROGNOSTICS, INC. | A Award deriv | 2023-06-08 | 2023-07-07 | 63,265 | — | $0 | 63,265 | SEC↗ |
| OMIC Singular Genomics Systems, | A Award deriv | 2023-05-25 | 2023-05-26 | 74,000 | — | $0 | 74,000 | SEC↗ |
| SERA SERA PROGNOSTICS, INC. | A Award deriv | 2022-06-03 | 2022-06-06 | 149,675 | — | $0 | 149,675 | SEC↗ |
| OMIC Singular Genomics Systems, | A Award deriv | 2022-05-26 | 2022-05-31 | 46,250 | — | $0 | 46,250 | SEC↗ |
| EVFM Evofem Biosciences, Inc. | A Award deriv | 2022-05-04 | 2022-05-06 | 6,000 | — | $0 | 6,000 | SEC↗ |
| EVFM Evofem Biosciences, Inc. | P Buy | 2021-06-18 | 2021-06-21 | 10,000 | $1.17 | $11.7K | 19,287 | SEC↗ |
| OMIC Singular Genomics Systems, | C Conversion deriv | 2021-06-01 | 2021-06-01 | 1,293,243 | — | $0 | 0 | SEC↗ |
| OMIC Singular Genomics Systems, | C Conversion deriv | 2021-06-01 | 2021-06-01 | 435,609 | — | $0 | 0 | SEC↗ |
| OMIC Singular Genomics Systems, | C Conversion deriv | 2021-06-01 | 2021-06-01 | 2,666,781 | — | $0 | 0 | SEC↗ |
| OMIC Singular Genomics Systems, | C Conversion | 2021-06-01 | 2021-06-01 | 4,395,633 | — | $0 | 4,495,633 | SEC↗ |
| EVFM Evofem Biosciences, Inc. | A Award deriv | 2021-05-12 | 2021-05-13 | 90,000 | — | $0 | 90,000 | SEC↗ |
| OBLN OBALON THERAPEUTICS INC | A Award deriv | 2020-09-16 | 2020-09-18 | 27,250 | — | $0 | 27,250 | SEC↗ |
| OBLN OBALON THERAPEUTICS INC | A Award deriv | 2020-09-16 | 2020-09-18 | 27,250 | — | $0 | 27,250 | SEC↗ |
| EVFM Evofem Biosciences, Inc. | P Buy | 2020-06-12 | 2020-06-16 | 5,000 | $2.94 | $14.7K | 9,287 | SEC↗ |
| EVFM Evofem Biosciences, Inc. | A Award deriv | 2020-05-12 | 2020-05-13 | 50,000 | — | $0 | 50,000 | SEC↗ |
| OBLN OBALON THERAPEUTICS INC | P Buy deriv | 2019-08-06 | 2019-08-08 | 9,375 | $4.00 | $37.5K | 9,375 | SEC↗ |
| OBLN OBALON THERAPEUTICS INC | P Buy | 2019-08-06 | 2019-08-08 | 12,500 | $4.00 | $50.0K | 27,148 | SEC↗ |
| OBLN OBALON THERAPEUTICS INC | A Award | 2019-07-23 | 2019-07-25 | 78,125 | — | $0 | 146,470 | SEC↗ |
| EVFM Evofem Biosciences, Inc. | A Award deriv | 2019-06-05 | 2019-06-07 | 50,000 | — | $0 | 50,000 | SEC↗ |
| EVFM Evofem Biosciences, Inc. | J Other | 2019-05-22 | 2019-05-23 | 4,287 | — | $0 | 4,287 | SEC↗ |
| EVFM Evofem Biosciences, Inc. | S Sale | 2019-05-21 | 2019-05-23 | 655 | $5.07 | $3.3K | 0 | SEC↗ |
| OBLN OBALON THERAPEUTICS INC | P Buy | 2018-08-23 | 2018-08-27 | 54,945 | $1.82 | $100.0K | 68,345 | SEC↗ |
| OBLN OBALON THERAPEUTICS INC | A Award deriv | 2018-06-13 | 2018-06-15 | 81,774 | — | $0 | 81,774 | SEC↗ |
| EVFM Evofem Biosciences, Inc. | A Award deriv | 2018-05-08 | 2018-05-10 | 12,875 | — | $0 | 12,875 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | D To issuer | 2017-12-11 | 2017-12-13 | 47,963 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | A Award deriv | 2017-06-20 | 2017-06-22 | 12,450 | — | $0 | 12,450 | SEC↗ |
| OBLN OBALON THERAPEUTICS INC | A Award deriv | 2017-06-06 | 2017-06-19 | 36,554 | — | $0 | 36,554 | SEC↗ |
| NEOT Neothetics, Inc. | A Award deriv | 2017-05-11 | 2017-05-15 | 63,500 | — | $0 | 63,500 | SEC↗ |
| OBLN OBALON THERAPEUTICS INC | A Award deriv | 2017-05-09 | 2017-05-11 | 21,000 | — | $0 | 21,000 | SEC↗ |
| OBLN OBALON THERAPEUTICS INC | A Award deriv | 2016-11-09 | 2016-11-14 | 46,500 | — | $0 | 46,500 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | D To issuer deriv | 2016-11-01 | 2016-11-04 | 1,071 | — | $0 | 0 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | D To issuer deriv | 2016-11-01 | 2016-11-04 | 17,695 | — | $0 | 0 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | D To issuer deriv | 2016-11-01 | 2016-11-04 | 1,996 | — | $0 | 0 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | U Tender | 2016-11-01 | 2016-11-04 | 38,094 | $28.35 | $1.08M | 0 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | A Award deriv | 2016-10-31 | 2016-11-02 | 8,000 | — | $0 | 8,000 | SEC↗ |
| OBLN OBALON THERAPEUTICS INC | P Buy | 2016-10-12 | 2016-10-14 | 13,400 | $15.00 | $201.0K | 13,400 | SEC↗ |
| NEOT Neothetics, Inc. | A Award deriv | 2016-06-21 | 2016-06-23 | 12,450 | — | $0 | 12,450 | SEC↗ |
| NEOT Neothetics, Inc. | A Award deriv | 2016-06-21 | 2016-06-23 | 16,393 | — | $0 | 16,393 | SEC↗ |
| NEOT Neothetics, Inc. | A Award deriv | 2016-06-21 | 2016-06-23 | 24,590 | — | $0 | 24,590 | SEC↗ |
| NEOT Neothetics, Inc. | A Award deriv | 2015-06-16 | 2015-06-18 | 12,450 | — | $0 | 12,450 | SEC↗ |
| NEOT Neothetics, Inc. | A Award deriv | 2015-06-16 | 2015-06-18 | 23,940 | — | $0 | 23,940 | SEC↗ |
| TBRA Tibira Therapeutics, Inc. | J Other | 2015-05-04 | 2015-05-06 | 36,187 | — | $0 | 38,094 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | D To issuer | 2014-11-17 | 2014-11-18 | 6,250 | — | $0 | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer | 2014-03-19 | 2014-03-21 | 27,500 | $14.00 | $385.0K | 0 | SEC↗ |